BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 6901590)

  • 21. Hypocomplementaemia of poststreptococcal acute glomerulonephritis is associated with C3 nephritic factor (C3NeF) IgG autoantibody activity.
    Frémeaux-Bacchi V; Weiss L; Demouchy C; May A; Palomera S; Kazatchkine MD
    Nephrol Dial Transplant; 1994; 9(12):1747-50. PubMed ID: 7708258
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Molecular basis of complement resistance of human melanoma cells expressing the C3-cleaving membrane protease p65.
    Ollert MW; Kadlec JV; Petrella EC; Bredehorst R; Vogel CW
    Cancer Res; 1993 Feb; 53(3):592-9. PubMed ID: 8425193
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The fixation of C3b to pneumococcal cell wall polymers as a result of activation of the alternative complement pathway.
    Hummell DS; Berninger RW; Tomasz A; Winkelstein JA
    J Immunol; 1981 Oct; 127(4):1287-9. PubMed ID: 7024404
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Isolation and characterization of rat complement factor B and its interaction with cell-bound human C3.
    Daha MR; van Es LA
    Immunology; 1980 Dec; 41(4):849-55. PubMed ID: 6906329
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Selective and efficient inhibition of the alternative pathway of complement by a mAb that recognizes C3b/iC3b.
    DiLillo DJ; Pawluczkowycz AW; Peng W; Kennedy AD; Beum PV; Lindorfer MA; Taylor RP
    Mol Immunol; 2006 Mar; 43(7):1010-9. PubMed ID: 15961157
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Membranoproliferative glomerulonephritis with partial lipodystrophy: discordant occurrence in identical twins.
    Reichel W; Köbberling J; Fischbach H; Scheler F
    Klin Wochenschr; 1976 Jan; 54(2):75-81. PubMed ID: 129586
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Herpes gestationis associated with the C3 nephritic factor.
    Grimwood R; Arroyave CM; Weston WL; Aeling JL
    Arch Dermatol; 1980 Sep; 116(9):1045-7. PubMed ID: 6998378
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Human complement (C3b) receptors defined by a mouse monoclonal antibody.
    Gerdes J; Naiem M; Mason DY; Stein H
    Immunology; 1982 Apr; 45(4):645-53. PubMed ID: 7068171
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Interactions of human complement component C3 with factor B and with complement receptors type 1 (CR1, CD35) and type 3 (CR3, CD11b/CD18) involve an acidic sequence at the N-terminus of C3 alpha'-chain.
    Taniguchi-Sidle A; Isenman DE
    J Immunol; 1994 Dec; 153(11):5285-302. PubMed ID: 7963581
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Studies of complement, nephritic factor, and circulating immune complexes in chronic mesangiocapillary glomerulonephritis types I and II (author's transl)].
    Mirapeix E; Yagüe J; Vives J; Revert L
    Med Clin (Barc); 1981 Jun; 77(1):21-6. PubMed ID: 7253758
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Molecular analysis of C3 allotypes in patients with nephritic factor.
    Finn JE; Mathieson PW
    Clin Exp Immunol; 1993 Mar; 91(3):410-4. PubMed ID: 8443964
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Serum bactericidal activity against Neisseria meningitidis in patients with C3 nephritic factors is dependent on IgG allotypes.
    Skattum L; Gullstrand B; Holmström E; Oxelius VA; Truedsson L
    Clin Immunol; 2008 Oct; 129(1):123-31. PubMed ID: 18667363
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Immunological features of patients affected by Barraquer-Simons syndrome.
    Corvillo F; Ceccarini G; Nozal P; Magno S; Pelosini C; Garrido S; López-Lera A; Moraru M; Vilches C; Fornaciari S; Gabbriellini S; Santini F; Araújo-Vilar D; López-Trascasa M
    Orphanet J Rare Dis; 2020 Jan; 15(1):9. PubMed ID: 31924231
    [TBL] [Abstract][Full Text] [Related]  

  • 34. IgG subclass studies of C3 nephritic factor.
    Davis AE; Gelfand EW; Schur PH; Rosen FS; Alper CA
    Clin Immunol Immunopathol; 1978 Sep; 11(1):98-101. PubMed ID: 699392
    [No Abstract]   [Full Text] [Related]  

  • 35. Complement receptors on Raji cells. The presence of a new type of C3 receptor.
    Okuda T; Tachibana T
    Immunology; 1980 Sep; 41(1):159-66. PubMed ID: 7429548
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The clinical significance of partial lipoatrophy and C3 hypocomplementaemia: a report of two cases.
    Wayte J; Bird G; Wilkinson JD
    Clin Exp Dermatol; 1996 Mar; 21(2):131-4. PubMed ID: 8759201
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The interrelationship between hypocomplementaemia, partial lipodystrophy and mesangiocapillary glomerulonephritis.
    Wakefield MA
    Postgrad Med J; 1976 Oct; 52(612):651-2. PubMed ID: 995791
    [TBL] [Abstract][Full Text] [Related]  

  • 38. C3 nephritic factor in an individual with recurrent viral infection and lipodystrophy.
    Myers B; Chambers R; Anderson A; Barry R; Wallington T; Whicher J
    J Clin Lab Immunol; 1986 Apr; 19(4):201-4. PubMed ID: 3723590
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The role of cellular Fc and C3 receptors on the complement-dependent degradation of stable soluble immunoglobulin aggregates by normal and trypsin-treated peritoneal macrophages.
    Daha MR; van Es LA
    Immunology; 1982 Sep; 47(1):203-9. PubMed ID: 7118161
    [TBL] [Abstract][Full Text] [Related]  

  • 40. C3 nephritic factor and SLE: report of four cases and review of the literature.
    Walport MJ; Davies KA; Botto M; Naughton MA; Isenberg DA; Biasi D; Powell RJ; Cheung NT; Struthers GR
    QJM; 1994 Oct; 87(10):609-15. PubMed ID: 7987656
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.